top of page

Bitcoin, Tech and Crypto Meets Longevity: Capital’s Shared Bet on Time

  • lucia9168
  • Mar 10
  • 4 min read

At first glance, Bitcoin and longevity appear to belong to entirely different worlds.


Bitcoin emerged as a decentralized monetary network designed to preserve value across time. Longevity is an emerging sector spanning aging research, preventive medicine, diagnostics, supplements, and health optimization, all focused on extending healthy human lifespan.


Yet an increasing overlap between these ecosystems is becoming visible.


A number of founders and investors who helped build the cryptocurrency economy are now funding longevity research, supporting health optimization initiatives, and investing in companies working to slow or reverse biological aging.


The convergence is not accidental.


Both movements revolve around a similar underlying question:


How much control humans can exert over time?

Bitcoin attempts to protect financial value from erosion across decades.

Longevity seeks to preserve biological function across decades.

For a growing group of investors, both represent attempts to challenge systems once assumed to decline inevitably.


A Shared Ethos: Rejecting the “Inevitable”


Inflation slowly erodes the purchasing power of money.

Aging slowly erodes the resilience of the human body.

Both processes unfold gradually, compounding across time.


For most of history, both were accepted as structural realities rather than solvable problems.


Bitcoin challenged that assumption in finance.

Longevity is beginning to challenge it in biology.


Researchers increasingly view aging not simply as a natural process but as a biological system driven by cellular damage, metabolic regulation, and genetic pathways that may be measurable and eventually modifiable.


For investors used to thinking in long time horizons, the analogy becomes clear.


Inflation ≈ Aging


Comparison of financial inflation and biological aging as long-term entropy processes
Picture 1: Financial Entropy vs Biological Entropy — Inflation-driven monetary value erosion compared with aging-driven physiological decline over time. Source: [1], [2], [3], [4], [10]

Both financial systems and biological systems experience a similar form of long-term degradation.


In finance, inflation gradually reduces the value of currency.

In biology, aging gradually reduces physiological performance.


Both are examples of entropy acting across time.


Bitcoin attempts to counter financial entropy by enforcing scarcity and decentralization.

Longevity research attempts to counter biological entropy through cellular repair, metabolic optimization, and preventative medicine.


This conceptual overlap explains why many technologists and crypto investors have become interested in longevity.


Tech and Crypto Capital Finds Longevity


One of the clearest signals of the connection between these sectors is capital allocation.


Several founders and investors associated with the cryptocurrency ecosystem are already directing funding toward longevity.


Examples include:


Brian Armstrong – Coinbase

Armstrong co-founded NewLimit, a biotechnology company researching epigenetic reprogramming aimed at restoring youthful gene expression in human cells.


Vitalik Buterin – Ethereum

Buterin has donated millions to aging research initiatives including the SENS Research Foundation, one of the earliest organizations focused on repairing cellular damage associated with aging.


Justin Sun – TRON

Sun pledged $51 million toward a longevity prize designed to accelerate breakthroughs in life-extension research.


Charles Hoskinson – Cardano

Hoskinson announced plans to invest approximately $100 million into a longevity clinic and research facility focused on preventative medicine and lifespan extension.


Arthur Hayes – BitMEX

Hayes has invested in companies working on stem-cell biotechnology and regenerative medicine.


Beyond the crypto ecosystem itself, several technology investors are also funding longevity companies:


  • Jeff Bezos – investor in Altos Labs, researching cellular reprogramming (they raised $3 billion so far)

  • Sam Altman – backing Retro Biosciences, funded with roughly $180 million

  • Brian Armstrong – through NewLimit, targeting epigenetic rejuvenation


These investments suggest a broader trend: capital created in frontier technologies increasingly flows toward longevity.


Crypto and technology investors funding longevity companies and research initiatives
Picture 2: Crypto & Technology Capital Entering Longevity — Selected founders and investors from the cryptocurrency and technology sectors funding longevity companies and aging research initiatives. Source: [1], [2], [4], [9]

Longevity Infrastructure Meets Crypto Infrastructure


The convergence is not limited to investors.

New infrastructure is also emerging at the intersection of crypto and longevity.


Decentralized science platforms such as Molecule and VitaDAO are experimenting with new ways to fund and coordinate biomedical research.


These models use blockchain systems to:

  • fund scientific research

  • distribute intellectual property ownership

  • enable global collaboration between researchers and investors


The idea is simple but powerful:

Use decentralized networks to accelerate scientific discovery.

In this sense, crypto infrastructure may become an unexpected catalyst for longevity research.


Longevity technology stack showing infrastructure biology platforms therapeutics diagnostics and application layer
Picture 3: The Longevity Technology Stack - The emerging ecosystem spanning research infrastructure, biology platforms, therapeutics, diagnostics, and longevity service providers. Source: [4], [8], [11]

Outlook: Biology Becomes the Next Frontier


Longevity remains an early-stage sector relative to its potential scale.


But the forces driving its growth are already visible.


Global populations are aging rapidly. By 2050 the number of people aged 65 and older is expected to double, placing enormous pressure on healthcare systems and economic productivity.


At the same time, advances in aging biology - including cellular reprogramming, biomarker diagnostics, and regenerative medicine - are transforming aging from an abstract concept into a measurable biological process.


For investors accustomed to identifying transformative technologies early, the pattern may look familiar.

Bitcoin challenged the architecture of financial systems.

Longevity may ultimately challenge the architecture of biological aging.


Both revolutions are rooted in the same ambition:

Extending human agency across time.

The ideas explored in this article build on insights shared by Marc P. Bernegger, Founding Partner of Maximon and Longevity Investors, during his talk at the Plan ₿ Forum in Lugano (October 2025).


In the presentation, Bernegger examined the emerging intersection between Bitcoin, frontier technology capital, and longevity science, highlighting how capital created in the crypto ecosystem is increasingly flowing into research aimed at extending human healthspan. The talk and its themes were also covered in Maximon’s event recap:


Watch the full talk:


Speaker profile:


Event highlight:


Sources


[10] World Health Organization — Global Health and Aging Report

[11] López-Otín et al. — The Hallmarks of Aging, Cell (Nature/Cell research)


Comments


  • Facebook
  • Instagram
  • X
  • TikTok

 

© 2025 by LI News.

 

bottom of page